{"id":"metronidazole-0-8","safety":{"commonSideEffects":[{"rate":null,"effect":"Metallic taste"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Local irritation (topical)"}]},"_chembl":{"chemblId":"CHEMBL137","moleculeType":"Small molecule","molecularWeight":"171.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is activated by anaerobic organisms and parasites through reduction of its 5-nitro group, generating short-lived reactive intermediates that damage DNA and inhibit nucleic acid synthesis. This mechanism is selective for anaerobic bacteria and certain parasites, making it effective against obligate anaerobes and protozoa while having minimal activity against aerobic organisms. The 0.8% topical formulation is designed for localized delivery to affected tissues.","oneSentence":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after reduction of its nitro group.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:21:03.833Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaerobic bacterial infections (topical formulation)"},{"name":"Parasitic infections (potential indication under investigation)"}]},"trialDetails":[{"nctId":"NCT03508999","phase":"PHASE4","title":"Effectiveness of Metronidazole Gel and Mobile SMS Reminders on Gingivitis in Orthodontic Patients","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2018-05-23","conditions":"Gingivitis","enrollment":63},{"nctId":"NCT03142607","phase":"PHASE3","title":"Comparative Evaluation of Chlorhexidine, Metronidazole and Combination Gels on Gingivitis","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2017-02-03","conditions":"Gingivitis","enrollment":90},{"nctId":"NCT02635191","phase":"PHASE4","title":"Tailored Therapy for Helicobacter Pylori in Children","status":"UNKNOWN","sponsor":"Beijing Children's Hospital","startDate":"2014-03","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT02394821","phase":"PHASE3","title":"Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2013-09","conditions":"Neoplasm, Wounds and Injuries","enrollment":24},{"nctId":"NCT02365389","phase":"PHASE2, PHASE3","title":"Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2014-05","conditions":"Vaginitis","enrollment":64}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Metronidazole 0.8%","genericName":"Metronidazole 0.8%","companyName":"University of Sao Paulo","companyId":"university-of-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after reduction of its nitro group. Used for Anaerobic bacterial infections (topical formulation), Parasitic infections (potential indication under investigation).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}